APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cat Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cat Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchCat Vaccines Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Cat Vaccines Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Cat Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cat Vaccines Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Cat Vaccines Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Cat Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cat Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cat Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cat Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cat Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cat Vaccines include Zoetis (Pfizer), Eli Lilly, Bayer Healthcare, Virbac, Vetoquinol S.A, Merial (Sanofi), Merck Animal Health, Heska Co. and Ceva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cat Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cat Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cat Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cat Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Cat Vaccines Segment by Company

Zoetis (Pfizer)

Eli Lilly

Bayer Healthcare

Virbac

Vetoquinol S.A

Merial (Sanofi)

Merck Animal Health

Heska Co.

Ceva

Boehringer Ingelheim

Cat Vaccines Segment by Type

DNA Vaccines

Conjugate Vaccines

Attenuated Live Vaccines

Toxoid Vaccines

Inactivated Vaccines

Subunit Vaccines

Recombinant Vaccines

Cat Vaccines Segment by Application

Below 6 Months

Above 6 Months

Cat Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cat Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cat Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cat Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cat Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cat Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cat Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cat Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cat Vaccines Industry Trends Table 2. Cat Vaccines Industry Drivers Table 3. Cat Vaccines Industry Opportunities and Challenges Table 4. Cat Vaccines Industry Restraints Table 5. Global Cat Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cat Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cat Vaccines Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Cat Vaccines Sales Market Share by Manufacturers Table 9. Global Cat Vaccines Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Cat Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cat Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cat Vaccines Manufacturers, Product Type & Application Table 13. Global Cat Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cat Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of DNA Vaccines Table 17. Major Manufacturers of Conjugate Vaccines Table 18. Major Manufacturers of Attenuated Live Vaccines Table 19. Major Manufacturers of Toxoid Vaccines Table 20. Major Manufacturers of Inactivated Vaccines Table 21. Major Manufacturers of Subunit Vaccines Table 22. Major Manufacturers of Recombinant Vaccines Table 23. Global Cat Vaccines Sales by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Cat Vaccines Sales by Type (2021-2026) & (k units) Table 25. Global Cat Vaccines Sales by Type (2027-2032) & (k units) Table 26. Global Cat Vaccines Sales Market Share by Type (2021-2026) Table 27. Global Cat Vaccines Sales Market Share by Type (2027-2032) Table 28. Global Cat Vaccines Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 29. Global Cat Vaccines Revenue by Type (2021-2026) & (k units) Table 30. Global Cat Vaccines Revenue by Type (2027-2032) & (k units) Table 31. Global Cat Vaccines Revenue Market Share by Type (2021-2026) Table 32. Global Cat Vaccines Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Below 6 Months Table 34. Major Manufacturers of Above 6 Months Table 35. Global Cat Vaccines Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Cat Vaccines Sales by Application (2021-2026) & (k units) Table 37. Global Cat Vaccines Sales by Application (2027-2032) & (k units) Table 38. Global Cat Vaccines Sales Market Share by Application (2021-2026) Table 39. Global Cat Vaccines Sales Market Share by Application (2027-2032) Table 40. Global Cat Vaccines Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Cat Vaccines Revenue by Application (2021-2026) & (k units) Table 42. Global Cat Vaccines Revenue by Application (2027-2032) & (k units) Table 43. Global Cat Vaccines Revenue Market Share by Application (2021-2026) Table 44. Global Cat Vaccines Revenue Market Share by Application (2027-2032) Table 45. Global Cat Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Cat Vaccines Sales by Region (2021-2026) & (k units) Table 47. Global Cat Vaccines Sales Market Share by Region (2021-2026) Table 48. Global Cat Vaccines Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Cat Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Cat Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Cat Vaccines Sales by Country (2021-2026) & (k units) Table 52. North America Cat Vaccines Sales by Country (2027-2032) & (k units) Table 53. Europe Cat Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Cat Vaccines Sales by Country (2021-2026) & (k units) Table 55. Europe Cat Vaccines Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Cat Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Cat Vaccines Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Cat Vaccines Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Cat Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Cat Vaccines Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Cat Vaccines Sales by Country (2027-2032) & (k units) Table 62. Global Cat Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Cat Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Cat Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Cat Vaccines Revenue Market Share by Region (2021-2026) Table 66. Global Cat Vaccines Revenue Market Share by Region (2027-2032) Table 67. Zoetis (Pfizer) Company Information Table 68. Zoetis (Pfizer) Business Overview Table 69. Zoetis (Pfizer) Cat Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Zoetis (Pfizer) Cat Vaccines Product Portfolio Table 71. Zoetis (Pfizer) Recent Development Table 72. Eli Lilly Company Information Table 73. Eli Lilly Business Overview Table 74. Eli Lilly Cat Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Eli Lilly Cat Vaccines Product Portfolio Table 76. Eli Lilly Recent Development Table 77. Bayer Healthcare Company Information Table 78. Bayer Healthcare Business Overview Table 79. Bayer Healthcare Cat Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Bayer Healthcare Cat Vaccines Product Portfolio Table 81. Bayer Healthcare Recent Development Table 82. Virbac Company Information Table 83. Virbac Business Overview Table 84. Virbac Cat Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Virbac Cat Vaccines Product Portfolio Table 86. Virbac Recent Development Table 87. Vetoquinol S.A Company Information Table 88. Vetoquinol S.A Business Overview Table 89. Vetoquinol S.A Cat Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Vetoquinol S.A Cat Vaccines Product Portfolio Table 91. Vetoquinol S.A Recent Development Table 92. Merial (Sanofi) Company Information Table 93. Merial (Sanofi) Business Overview Table 94. Merial (Sanofi) Cat Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Merial (Sanofi) Cat Vaccines Product Portfolio Table 96. Merial (Sanofi) Recent Development Table 97. Merck Animal Health Company Information Table 98. Merck Animal Health Business Overview Table 99. Merck Animal Health Cat Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Merck Animal Health Cat Vaccines Product Portfolio Table 101. Merck Animal Health Recent Development Table 102. Heska Co. Company Information Table 103. Heska Co. Business Overview Table 104. Heska Co. Cat Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Heska Co. Cat Vaccines Product Portfolio Table 106. Heska Co. Recent Development Table 107. Ceva Company Information Table 108. Ceva Business Overview Table 109. Ceva Cat Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Ceva Cat Vaccines Product Portfolio Table 111. Ceva Recent Development Table 112. Boehringer Ingelheim Company Information Table 113. Boehringer Ingelheim Business Overview Table 114. Boehringer Ingelheim Cat Vaccines Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Boehringer Ingelheim Cat Vaccines Product Portfolio Table 116. Boehringer Ingelheim Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Cat Vaccines Distributors List Table 120. Cat Vaccines Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Cat Vaccines Product Image Figure 2. Global Cat Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cat Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Cat Vaccines Sales (2021-2032) & (k units) Figure 5. Global Cat Vaccines Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cat Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. DNA Vaccines Image Figure 9. Conjugate Vaccines Image Figure 10. Attenuated Live Vaccines Image Figure 11. Toxoid Vaccines Image Figure 12. Inactivated Vaccines Image Figure 13. Subunit Vaccines Image Figure 14. Recombinant Vaccines Image Figure 15. Global Cat Vaccines Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Cat Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Cat Vaccines Sales Market Share by Type (2021-2032) Figure 18. Global Cat Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Cat Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Cat Vaccines Revenue Market Share by Type (2021-2032) Figure 21. Below 6 Months Image Figure 22. Above 6 Months Image Figure 23. Global Cat Vaccines Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Cat Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Cat Vaccines Sales Market Share by Application (2021-2032) Figure 26. Global Cat Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Cat Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Cat Vaccines Revenue Market Share by Application (2021-2032) Figure 29. North America Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Cat Vaccines Sales Market Share by Country (2021-2032) Figure 31. U.S. Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Cat Vaccines Sales Market Share by Country (2021-2032) Figure 36. Germany Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Cat Vaccines Sales Market Share by Country (2021-2032) Figure 43. China Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Cat Vaccines Sales Market Share by Country (2021-2032) Figure 51. Brazil Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Cat Vaccines Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Cat Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Cat Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Cat Vaccines Revenue (2021-2032) & (US$ Million) Figure 62. North America Cat Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Cat Vaccines Revenue (2021-2032) & (US$ Million) Figure 64. Europe Cat Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Cat Vaccines Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Cat Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Cat Vaccines Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Cat Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Cat Vaccines Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Cat Vaccines Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • DNA Vaccines
  • Conjugate Vaccines
  • Attenuated Live Vaccines
  • Toxoid Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Recombinant Vaccines
Applications
  • Below 6 Months
  • Above 6 Months
Companies covered
  • Zoetis (Pfizer)
  • Eli Lilly
  • Bayer Healthcare
  • Virbac
  • Vetoquinol S.A
  • Merial (Sanofi)
  • Merck Animal Health
  • Heska Co.
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cat Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cat Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cat Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cat Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cat Vaccines Market Dynamics
  1. 2.1 Cat Vaccines Industry Trends
  2. 2.2 Cat Vaccines Industry Drivers
  3. 2.3 Cat Vaccines Industry Opportunities and Challenges
  4. 2.4 Cat Vaccines Industry Restraints
3 Cat Vaccines Market by Manufacturers
  1. 3.1 Global Cat Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cat Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cat Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cat Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cat Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cat Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Cat Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cat Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cat Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cat Vaccines Tier 1, Tier 2, and Tier 3
4 Cat Vaccines Market by Type
  1. 4.1 Cat Vaccines Type Introduction
  2. 4.1.1 DNA Vaccines
  3. 4.1.2 Conjugate Vaccines
  4. 4.1.3 Attenuated Live Vaccines
  5. 4.1.4 Toxoid Vaccines
  6. 4.1.5 Inactivated Vaccines
  7. 4.1.6 Subunit Vaccines
  8. 4.1.7 Recombinant Vaccines
  9. 4.2 Global Cat Vaccines Sales by Type
  10. 4.2.1 Global Cat Vaccines Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Cat Vaccines Sales by Type (2021-2032)
  12. 4.2.3 Global Cat Vaccines Sales Market Share by Type (2021-2032)
  13. 4.3 Global Cat Vaccines Revenue by Type
  14. 4.3.1 Global Cat Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Cat Vaccines Revenue by Type (2021-2032)
  16. 4.3.3 Global Cat Vaccines Revenue Market Share by Type (2021-2032)
5 Cat Vaccines Market by Application
  1. 5.1 Cat Vaccines Application Introduction
  2. 5.1.1 Below 6 Months
  3. 5.1.2 Above 6 Months
  4. 5.2 Global Cat Vaccines Sales by Application
  5. 5.2.1 Global Cat Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Cat Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global Cat Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global Cat Vaccines Revenue by Application
  9. 5.3.1 Global Cat Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Cat Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global Cat Vaccines Revenue Market Share by Application (2021-2032)
6 Global Cat Vaccines Sales by Region
  1. 6.1 Global Cat Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cat Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Cat Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Cat Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cat Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cat Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cat Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cat Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cat Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cat Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cat Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cat Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cat Vaccines Revenue by Region
  1. 7.1 Global Cat Vaccines Revenue by Region
  2. 7.1.1 Global Cat Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cat Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Cat Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Cat Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cat Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Cat Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cat Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Cat Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cat Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cat Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cat Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cat Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis (Pfizer)
  2. 8.1.1 Zoetis (Pfizer) Company Information
  3. 8.1.2 Zoetis (Pfizer) Business Overview
  4. 8.1.3 Zoetis (Pfizer) Cat Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis (Pfizer) Cat Vaccines Product Portfolio
  6. 8.1.5 Zoetis (Pfizer) Recent Developments
  7. 8.2 Eli Lilly
  8. 8.2.1 Eli Lilly Company Information
  9. 8.2.2 Eli Lilly Business Overview
  10. 8.2.3 Eli Lilly Cat Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly Cat Vaccines Product Portfolio
  12. 8.2.5 Eli Lilly Recent Developments
  13. 8.3 Bayer Healthcare
  14. 8.3.1 Bayer Healthcare Company Information
  15. 8.3.2 Bayer Healthcare Business Overview
  16. 8.3.3 Bayer Healthcare Cat Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Healthcare Cat Vaccines Product Portfolio
  18. 8.3.5 Bayer Healthcare Recent Developments
  19. 8.4 Virbac
  20. 8.4.1 Virbac Company Information
  21. 8.4.2 Virbac Business Overview
  22. 8.4.3 Virbac Cat Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Virbac Cat Vaccines Product Portfolio
  24. 8.4.5 Virbac Recent Developments
  25. 8.5 Vetoquinol S.A
  26. 8.5.1 Vetoquinol S.A Company Information
  27. 8.5.2 Vetoquinol S.A Business Overview
  28. 8.5.3 Vetoquinol S.A Cat Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Vetoquinol S.A Cat Vaccines Product Portfolio
  30. 8.5.5 Vetoquinol S.A Recent Developments
  31. 8.6 Merial (Sanofi)
  32. 8.6.1 Merial (Sanofi) Company Information
  33. 8.6.2 Merial (Sanofi) Business Overview
  34. 8.6.3 Merial (Sanofi) Cat Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merial (Sanofi) Cat Vaccines Product Portfolio
  36. 8.6.5 Merial (Sanofi) Recent Developments
  37. 8.7 Merck Animal Health
  38. 8.7.1 Merck Animal Health Company Information
  39. 8.7.2 Merck Animal Health Business Overview
  40. 8.7.3 Merck Animal Health Cat Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck Animal Health Cat Vaccines Product Portfolio
  42. 8.7.5 Merck Animal Health Recent Developments
  43. 8.8 Heska Co.
  44. 8.8.1 Heska Co. Company Information
  45. 8.8.2 Heska Co. Business Overview
  46. 8.8.3 Heska Co. Cat Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Heska Co. Cat Vaccines Product Portfolio
  48. 8.8.5 Heska Co. Recent Developments
  49. 8.9 Ceva
  50. 8.9.1 Ceva Company Information
  51. 8.9.2 Ceva Business Overview
  52. 8.9.3 Ceva Cat Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ceva Cat Vaccines Product Portfolio
  54. 8.9.5 Ceva Recent Developments
  55. 8.10 Boehringer Ingelheim
  56. 8.10.1 Boehringer Ingelheim Company Information
  57. 8.10.2 Boehringer Ingelheim Business Overview
  58. 8.10.3 Boehringer Ingelheim Cat Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Boehringer Ingelheim Cat Vaccines Product Portfolio
  60. 8.10.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cat Vaccines Value Chain Analysis
  2. 9.1.1 Cat Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cat Vaccines Production Mode & Process
  6. 9.2 Cat Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cat Vaccines Distributors
  9. 9.2.3 Cat Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst